Roux-en-Y Gastrointestinal Bypass Promotes Activation of TGR5 and Peptide YY
- 15 October 2020
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Endocrine, Metabolic & Immune Disorders - Drug Targets
- Vol. 20 (8), 1262-1267
- https://doi.org/10.2174/1871530320666200628024500
Abstract
Background: G protein-coupled bile acid receptor (TGR5) is involved in a number of metabolic diseases. The aim of this study was to identify the role of TGR5 after Roux-en-Y gastric bypass (GBP). Methods: Wild type and TGR5 knockout mice (tgr5-/-) were fed a high-fat diet (HFD) to establish the obesity model. GBP was performed. The changes in body weight and food intake were measured. The levels of TGR5 and peptide YY (PYY) were evaluated by RT-PCR, Western blot, and ELISA. Moreover, the L-cells were separated from wild type and tgr5-/- mice. The levels of PYY in L-cells were evaluated by ELISA. Results: The body weights were significantly decreased after GBP in wild type mice (p<0.05), but not tgr5-/- mice (p>0.05). Food intake was reduced after GBP in wild type mice, but also not significantly affected in tgr5-/- mice (p>0.05). The levels of PYY were significantly increased after GBP compared with the sham group (p<0.05); however, in tgr5-/- mice the expression of PYY was not significantly affected (p>0.05). After INT-777 stimulation in L-cells obtained from murine intestines, the levels of PYY were significantly increased in L-cells tgr5+/+ (p<0.05). Conclusion: Our study suggests that GBP up-regulated the expression of TGR5 in murine intestines, and increased the levels of PYY, which further reduced food intake and decreased the body weight.Keywords
Funding Information
- Major Scientific Research Project of Changzhou Health and Family Planning Commission (ZD201606)
This publication has 30 references indexed in Scilit:
- Weight-Independent Effects of Roux-en-Y Gastric Bypass on Glucose Homeostasis via Melanocortin-4 Receptors in Mice and HumansGastroenterology, 2013
- Bariatric Surgery versus Conventional Medical Therapy for Type 2 DiabetesThe New England Journal of Medicine, 2012
- Bariatric surgery: Mechanisms, indications and outcomesJournal of Gastroenterology and Hepatology, 2010
- Targeting the TGR5-GLP-1 pathway to combat type 2 diabetes and non-alcoholic fatty liver diseaseGastroentérologie Clinique et Biologique, 2010
- Discovery of 6α-Ethyl-23(S)-methylcholic Acid (S-EMCA, INT-777) as a Potent and Selective Agonist for the TGR5 Receptor, a Novel Target for DiabesityJournal of Medicinal Chemistry, 2009
- Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid MetabolismObesity, 2009
- High expression levels of IKKα and IKKβ are necessary for the malignant properties of liver cancerInternational Journal of Cancer, 2009
- The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladdersJournal of Hepatology, 2009
- Expression and function of the bile acid receptor TGR5 in Kupffer cellsBiochemical and Biophysical Research Communications, 2008
- Bile acids induce energy expenditure by promoting intracellular thyroid hormone activationNature, 2006